Global Non-Opioid Patch Market Growth 2024-2030

Publication ID:

LPI08246071

Publication Date:

August 21, 2024

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

A Non-Opioid Patch is a transdermal patch used for pain management. Unlike opioid-based patches, non-opioid patches deliver medications that are not opioids, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or lidocaine, to provide pain relief without the risk of opioid addiction or dependence.
The global Non-Opioid Patch market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淣on-Opioid Patch Industry Forecast鈥� looks at past sales and reviews total world Non-Opioid Patch sales in 2023, providing a comprehensive analysis by region and market sector of projected Non-Opioid Patch sales for 2024 through 2030. With Non-Opioid Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Opioid Patch industry.
This Insight Report provides a comprehensive analysis of the global Non-Opioid Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Opioid Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Non-Opioid Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Opioid Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Opioid Patch.
A Non-Opioid Patch is a medical patch or transdermal delivery system that releases medications for pain relief without containing opioids. These patches are used to manage various types of pain, such as chronic pain, post-surgery pain, or pain associated with certain medical conditions.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Opioid Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Prescription Medicines
OTC Medicines
Segmentation by application
Hospital Pharmacies
Drug Stores
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NEXGEL Advanced Hydrogel Solutions
Viatris Inc.
Johnson and Johnson
Teva Pharmaceutical Industries Ltd
Sorrento Therapeutics Inc.
Hisamitsu Pharmaceutical Co.,Inc.
Endo International plc.
Purdue Pharma L.P.
Amneal Pharmaceuticals LLC
Grunenthal
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-Opioid Patch market?
What factors are driving Non-Opioid Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-Opioid Patch market opportunities vary by end market size?
How does Non-Opioid Patch break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Opioid Patch Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Non-Opioid Patch by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Non-Opioid Patch by Country/Region, 2019, 2023 & 2030
2.2 Non-Opioid Patch Segment by Type
2.2.1 Prescription Medicines
2.2.2 OTC Medicines
2.3 Non-Opioid Patch Sales by Type
2.3.1 Global Non-Opioid Patch Sales Market Share by Type (2019-2024)
2.3.2 Global Non-Opioid Patch Revenue and Market Share by Type (2019-2024)
2.3.3 Global Non-Opioid Patch Sale Price by Type (2019-2024)
2.4 Non-Opioid Patch Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.4.3 Online Pharmacies
2.5 Non-Opioid Patch Sales by Application
2.5.1 Global Non-Opioid Patch Sale Market Share by Application (2019-2024)
2.5.2 Global Non-Opioid Patch Revenue and Market Share by Application (2019-2024)
2.5.3 Global Non-Opioid Patch Sale Price by Application (2019-2024)
3 Global Non-Opioid Patch by Company
3.1 Global Non-Opioid Patch Breakdown Data by Company
3.1.1 Global Non-Opioid Patch Annual Sales by Company (2019-2024)
3.1.2 Global Non-Opioid Patch Sales Market Share by Company (2019-2024)
3.2 Global Non-Opioid Patch Annual Revenue by Company (2019-2024)
3.2.1 Global Non-Opioid Patch Revenue by Company (2019-2024)
3.2.2 Global Non-Opioid Patch Revenue Market Share by Company (2019-2024)
3.3 Global Non-Opioid Patch Sale Price by Company
3.4 Key Manufacturers Non-Opioid Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Opioid Patch Product Location Distribution
3.4.2 Players Non-Opioid Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-Opioid Patch by Geographic Region
4.1 World Historic Non-Opioid Patch Market Size by Geographic Region (2019-2024)
4.1.1 Global Non-Opioid Patch Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Non-Opioid Patch Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Non-Opioid Patch Market Size by Country/Region (2019-2024)
4.2.1 Global Non-Opioid Patch Annual Sales by Country/Region (2019-2024)
4.2.2 Global Non-Opioid Patch Annual Revenue by Country/Region (2019-2024)
4.3 Americas Non-Opioid Patch Sales Growth
4.4 APAC Non-Opioid Patch Sales Growth
4.5 Europe Non-Opioid Patch Sales Growth
4.6 Middle East & Africa Non-Opioid Patch Sales Growth
5 Americas
5.1 Americas Non-Opioid Patch Sales by Country
5.1.1 Americas Non-Opioid Patch Sales by Country (2019-2024)
5.1.2 Americas Non-Opioid Patch Revenue by Country (2019-2024)
5.2 Americas Non-Opioid Patch Sales by Type
5.3 Americas Non-Opioid Patch Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Opioid Patch Sales by Region
6.1.1 APAC Non-Opioid Patch Sales by Region (2019-2024)
6.1.2 APAC Non-Opioid Patch Revenue by Region (2019-2024)
6.2 APAC Non-Opioid Patch Sales by Type
6.3 APAC Non-Opioid Patch Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-Opioid Patch by Country
7.1.1 Europe Non-Opioid Patch Sales by Country (2019-2024)
7.1.2 Europe Non-Opioid Patch Revenue by Country (2019-2024)
7.2 Europe Non-Opioid Patch Sales by Type
7.3 Europe Non-Opioid Patch Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Opioid Patch by Country
8.1.1 Middle East & Africa Non-Opioid Patch Sales by Country (2019-2024)
8.1.2 Middle East & Africa Non-Opioid Patch Revenue by Country (2019-2024)
8.2 Middle East & Africa Non-Opioid Patch Sales by Type
8.3 Middle East & Africa Non-Opioid Patch Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Opioid Patch
10.3 Manufacturing Process Analysis of Non-Opioid Patch
10.4 Industry Chain Structure of Non-Opioid Patch
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Opioid Patch Distributors
11.3 Non-Opioid Patch Customer
12 World Forecast Review for Non-Opioid Patch by Geographic Region
12.1 Global Non-Opioid Patch Market Size Forecast by Region
12.1.1 Global Non-Opioid Patch Forecast by Region (2025-2030)
12.1.2 Global Non-Opioid Patch Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-Opioid Patch Forecast by Type
12.7 Global Non-Opioid Patch Forecast by Application
13 Key Players Analysis
13.1 NEXGEL Advanced Hydrogel Solutions
13.1.1 NEXGEL Advanced Hydrogel Solutions Company Information
13.1.2 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolios and Specifications
13.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 NEXGEL Advanced Hydrogel Solutions Main Business Overview
13.1.5 NEXGEL Advanced Hydrogel Solutions Latest Developments
13.2 Viatris Inc.
13.2.1 Viatris Inc. Company Information
13.2.2 Viatris Inc. Non-Opioid Patch Product Portfolios and Specifications
13.2.3 Viatris Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Viatris Inc. Main Business Overview
13.2.5 Viatris Inc. Latest Developments
13.3 Johnson and Johnson
13.3.1 Johnson and Johnson Company Information
13.3.2 Johnson and Johnson Non-Opioid Patch Product Portfolios and Specifications
13.3.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Johnson and Johnson Main Business Overview
13.3.5 Johnson and Johnson Latest Developments
13.4 Teva Pharmaceutical Industries Ltd
13.4.1 Teva Pharmaceutical Industries Ltd Company Information
13.4.2 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.4.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.5 Sorrento Therapeutics Inc.
13.5.1 Sorrento Therapeutics Inc. Company Information
13.5.2 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolios and Specifications
13.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sorrento Therapeutics Inc. Main Business Overview
13.5.5 Sorrento Therapeutics Inc. Latest Developments
13.6 Hisamitsu Pharmaceutical Co.,Inc.
13.6.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
13.6.2 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolios and Specifications
13.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Hisamitsu Pharmaceutical Co.,Inc. Main Business Overview
13.6.5 Hisamitsu Pharmaceutical Co.,Inc. Latest Developments
13.7 Endo International plc.
13.7.1 Endo International plc. Company Information
13.7.2 Endo International plc. Non-Opioid Patch Product Portfolios and Specifications
13.7.3 Endo International plc. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Endo International plc. Main Business Overview
13.7.5 Endo International plc. Latest Developments
13.8 Purdue Pharma L.P.
13.8.1 Purdue Pharma L.P. Company Information
13.8.2 Purdue Pharma L.P. Non-Opioid Patch Product Portfolios and Specifications
13.8.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Purdue Pharma L.P. Main Business Overview
13.8.5 Purdue Pharma L.P. Latest Developments
13.9 Amneal Pharmaceuticals LLC
13.9.1 Amneal Pharmaceuticals LLC Company Information
13.9.2 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolios and Specifications
13.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Amneal Pharmaceuticals LLC Main Business Overview
13.9.5 Amneal Pharmaceuticals LLC Latest Developments
13.10 Grunenthal
13.10.1 Grunenthal Company Information
13.10.2 Grunenthal Non-Opioid Patch Product Portfolios and Specifications
13.10.3 Grunenthal Non-Opioid Patch Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Grunenthal Main Business Overview
13.10.5 Grunenthal Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂